LSBio’s library of coronavirus products includes numerous kits for the detection of SARS, SARS-CoV-2, MERS, HCoV, FIPV, and other common coronaviruses. We offer COVID-19 real-time quantitative PCR (RT-qPCR) kits for the direct detection of SARS-CoV-2 RNA and lateral flow detection kits to identify anti-SARS-CoV-2 human IgG and IgM antibodies in serum. We also provide a wide range of ELISA kits to detect human IgG/IgM, coronavirus proteins, and host proteins relevant to COVID-19 disease progression.
LSBio’s viral sample collection and processing products are ideal for the collection, transport, and storage of viral samples. Our nucleic acid extraction kits can be used to generate high yields of top quality RNA, DNA, or plasmid DNA from various types of biological samples. Furthermore, our collection tubes will protect the integrity of the collected sample during transport and eliminate the need for dry ice. A unique formulation inactivates and stabilizes the virus for safe handling, and contains antibiotics that inhibit the growth of contaminating bacteria and fungi.
Lateral Flow tests are used for the detection of anti-coronavirus IgG and IgM antibodies in human serum. IgM is produced early in the immune response to viral infection. IgG is produced later in the immune response to the virus, and persists longer, so it serves as an indicator of ongoing or past infection. Kits are designed to detect IgG, IgM, or both antibodies. Lateral Flow kits are beneficial because they are rapid, easy to use, require minimal amounts of sample, and do not require specialized equipment.
This rapid test is for research use only and has not been approved by the FDA for clinical diagnostic use. Samples collected and processed for this test are potentially infectious, and should be handled only by trained laboratory professionals in a BL-2 laboratory or equivalent seting with a laminar flow hood and personal protective equipment.
Real-Time qPCR (RT-qPCR) is a technique that allows researchers to quantitatively detect the presence of specific RNA, such as SARS-CoV-2, within a sample. Following nucleic acid extraction and reverse transcription of RNA to cDNA, the polymerase chain reaction is used to amplify the target DNA, which is then detected using fluorescently labeled highly-specific probes. As the reaction progresses, the release of fluorescence can be monitored, providing a means of quantifying the target. In response to the COVID-19 pandemic, we offer both Real-Time qPCR kits and sample collection kits. The RT-qPCR kits require access to a real-time quantitative PCR instrument.
This rapid test is for research use only and has not been approved by the FDA for clinical diagnostic use. Samples collected and processed for this test are potentially infectious, and should be handled only by trained laboratory professionals in a BL-2 laboratory or equivalent setting with a laminar flow hood and personal protective equipment.
LSBio provides a range of Sandwich ELISA kits for the quantitative detection of numerous coronavirus proteins, including SARS-CoV and SARS-CoV-2 spike and nucleocapsid proteins. We also offer kits which detect the SARS-CoV-2 receptor ACE2, protease TMPRSS2, and numerous inflammatory proteins, such as IL-6, IL-10, and TNF-alpha.